Hormonal regulation of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus

Neurobiology of Learning and Memory

Volumn 95, Issue 2, 2011, Pages 206-220

  Williams, Tanya J ^a,b   Torres Reveron, Annelyn ^a,d   Chapleau, Jeanette D ^a   Milner, Teresa A ^a,c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Estrogen; Hippocampus; Hormones; Neuropeptide Y; Opioid peptides; Sex differences

Indexed keywords

DELTA OPIATE RECEPTOR; NEUROPEPTIDE Y; PEROXIDASE;

4 AMINOBUTYRIC ACID RELEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN FUNCTION; CELL LABELING; CONTROLLED STUDY; DENDRITE; DENTATE GYRUS; DENTATE HILUS; ESTRUS CYCLE; FEMALE; FLUORESCENCE ANALYSIS; GRANULE CELL; HIPPOCAMPUS; HORMONAL REGULATION; IMMUNOELECTRON MICROSCOPY; IMMUNOREACTIVITY; INTERNALIZATION; INTERNEURON; MALE; MICROSCOPY; NERVE FIBER; NONHUMAN; PROESTRUS; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; PYRAMIDAL NERVE CELL; RAT; STRATUM ORIENS; ULTRASTRUCTURE;

ANALYSIS OF VARIANCE; ANIMALS; AXONS; CELL COUNT; ESTRADIOL; ESTROUS CYCLE; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INTERNEURONS; MALE; MICROSCOPY, IMMUNOELECTRON; NEUROPEPTIDE Y; PYRAMIDAL CELLS; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA;

EID: 79951772346     PISSN: 10747427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nlm.2011.01.002     Document Type: Article

References (105)

1. Adams M.M., Oung T., Morrison J.H., Gore A.C. Length of postovariectomy interval and age, but not estrogen replacement, regulate N-methyl-D-aspartate receptor mRNA levels in the hippocampus of female rats. Experimental Neurology 2001, 170:345-356.
2. Afify E.A., Law P.Y., Riedl M., Elde R., Loh H.H. Role of carboxyl terminus of mu-and delta-opioid receptor in agonist-induced down-regulation. Brain Research Molecular Brain Research 1998, 54:24-34.
3. Ali A.B., Thomson A.M. Facilitating pyramid to horizontal oriens-alveus interneurone inputs: dual intracellular recordings in slices of rat hippocampus. Journal of Physiology 1998, 507(Pt 1):185-199.
4. Bao G., Kang L., Li H., Li Y., Pu L., Xia P., et al. Morphine and heroin differentially modulate in vivo hippocampal LTP in opiate-dependent rat. Neuropsychopharmacology 2007, 32:1738-1749.
5. Bausch S.B., Chavkin C. Changes in hippocampal circuitry after pilocarpine-induced seizures as revealed by opioid receptor distribution and activation. Journal of Neuroscience 1997, 17:477-492.
6. Belanger A., Cusan L., Caron S., Barden N., Dupont A. Ovarian progestins, androgens and estrogen throughout the 4-day estrous cycle in the rat. Biology of Reproduction 1981, 24:591-596.
7. Berke J.D., Hyman S.E. Addiction, dopamine, and the molecular mechanisms of memory. Neuron 2000, 25:515-532.
8. Bliss T.V., Collingridge G.L. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 1993, 361:31-39.
9. Bramham C.R., Sarvey J.M. Endogenous activation of mu and delta-1 opioid receptors is required for long-term potentiation induction in the lateral perforant path: Dependence on GABAergic inhibition. Journal of Neuroscience 1996, 16:8123-8131.
10. Cahill C.M., Morinville A., Lee M.C., Vincent J.P., Collier B., Beaudet A. Prolonged morphine treatment targets delta opioid receptors to neuronal plasma membranes and enhances delta-mediated antinociception. Journal of Neuroscience 2001, 21:7598-7607.
11. Chan J., Aoki C., Pickel V.M. Optimization of differential immunogold-silver and peroxidase labeling with maintenance of ultrastructure in brain sections before plastic embedding. Journal of Neuroscience Methods 1990, 33:113-127.
12. Chefer V.I., Shippenberg T.S. Augmentation of morphine-induced sensitization but reduction in morphine tolerance and reward in delta-opioid receptor knockout mice. Neuropsychopharmacology 2009, 34:887-898.
13. Cheng P.Y., Svingos A.L., Wang H., Clarke C.L., Jenab S., Beczkowska I.W., et al. Ultrastructural immunolabeling shows prominent presynaptic vesicular localization of delta-opioid receptor within both enkephalin- and nonenkephalin-containing axon terminals in the superficial layers of the rat cervical spinal cord. Journal of Neuroscience 1995, 15:5976-5988.
14. Ciccocioppo R., Martin-Fardon R., Weiss F. Effect of selective blockade of mu(1) or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 2002, 27:391-399.
15. Cohen G.A., Doze V.A., Madison D.V. Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons. Neuron 1992, 9:325-335.
16. Comer S.D., Lac S.T., Wyvell C.L., Carroll M.E. Combined effects of buprenorphine and a nondrug alternative reinforcer on i.v. Cocaine self-administration in rats maintained under FR schedules. Psychopharmacology 1996, 125:355-360.
17. Commons K.G., Milner T.A. Ultrastructural heterogeneity of enkephalin-containing terminals in the rat hippocampal formation. Journal of Comparative Neurology 1995, 358:324-342.
18. Commons K.G., Milner T.A. Cellular and subcellular localization of delta opioid receptor immunoreactivity in the rat dentate gyrus. Brain Research 1996, 738:181-195.
19. Commons K.G., Milner T.A. Localization of delta opioid receptor immunoreactivity in interneurons and pyramidal cells in the rat hippocampus. Journal of Comparative Neurology 1997, 381:373-387.
20. Cooke B.M., Woolley C.S. Gonadal hormone modulation of dendrites in the mammalian CNS. Journal of Neurobiology 2005, 64:34-46.
21. Corbett A.D., Gillan M.G., Kosterlitz H.W., McKnight A.T., Paterson S.J., Robson L.E. Selectivities of opioid peptide analogues as agonists and antagonists at the delta-receptor. British Journal of Pharmacology 1984, 83:271-279.
22. Croll S.D., Chesnutt C.R., Greene N.A., Lindsay R.M., Wiegand S.J. Peptide immunoreactivity in aged rat cortex and hippocampus as a function of memory and BDNF infusion. Pharmacology Biochemistry and Behavior 1999, 64:625-635.
23. Crombag H.S., Bossert J.M., Koya E., Shaham Y. Review. Context-induced relapse to drug seeking: A review. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences 2008, 363:3233-3243.
24. Drake C.T., Chavkin C., Milner T.A. Opioid systems in the dentate gyrus. Progress in Brain Research 2007, 163:245-263.
25. Drake C.T., Milner T.A. Mu opioid receptors are in discrete hippocampal interneuron subpopulations. Hippocampus 2002, 12:119-136.
26. Eckersell C.B., Popper P., Micevych P.E. Estrogen-induced alteration of mu-opioid receptor immunoreactivity in the medial preoptic nucleus and medial amygdala. Journal of Neuroscience 1998, 18:3967-3976.
27. Elman I., Karlsgodt K.H., Gastfriend D.R. Gender differences in cocaine craving among non-treatment-seeking individuals with cocaine dependence. American Journal of Drug and Alcohol Abuse 2001, 27:193-202.
28. Freund T.F., Buzsaki G. Interneurons of the hippocampus. Hippocampus 1996, 6:347-470.
29. Fuchs R.A., Eaddy J.L., Su Z.I., Bell G.H. Interactions of the basolateral amygdala with the dorsal hippocampus and dorsomedial prefrontal cortex regulate drug context-induced reinstatement of cocaine-seeking in rats. European Journal of Neuroscience 2007, 26:487-498.
30. Fuchs R.A., Evans K.A., Ledford C.C., Parker M.P., Case J.M., Mehta R.H., et al. The role of the dorsomedial prefrontal cortex, basolateral amygdala, and dorsal hippocampus in contextual reinstatement of cocaine seeking in rats. Neuropsychopharmacology 2005, 30:296-309.
31. Griffin M.L., Weiss R.D., Mirin S.M., Lange U. A comparison of male and female cocaine abusers. Archives of General Psychiatry 1989, 46:122-126.
32. Hara Y., Pickel V.M. Dendritic distributions of dopamine D1 receptors in the rat nucleus accumbens are synergistically affected by startle-evoking auditory stimulation and apomorphine. Neuroscience 2007, 146:1593-1605.
33. Hara Y., Yakovleva T., Bakalkin G., Pickel V.M. Dopamine D1 receptors have subcellular distributions conducive to interactions with prodynorphin in the rat nucleus accumbens shell. Synapse 2006, 60:1-19.
34. Harris K.M., Jensen F.E., Tsao B. Three-dimensional structure of dendritic spines and synapses in rat hippocampus (CA1) at postnatal day 15 and adult ages: Implications for the maturation of synaptic physiology and long-term potentiation. Journal of Neuroscience 1992, 12:2685-2705.
35. Holden C. Drug addiction. Zapping memory center triggers drug craving. Science 2001, 292:1039.
36. Hsu S.M., Raine L., Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. Journal of Histochemistry & Cytochemistry 1981, 29:577-580.
37. Hyman S.E., Malenka R.C. Addiction and the brain: the neurobiology of compulsion and its persistence. Nature Reviews Neuroscience 2001, 2:695-703.
38. Kippin T.E., Fuchs R.A., Mehta R.H., Case J.M., Parker M.P., Bimonte-Nelson H.A., et al. Potentiation of cocaine-primed reinstatement of drug seeking in female rats during estrus. Psychopharmacology 2005, 182:245-252.
39. Klein L.C., Popke E.J., Grunberg N.E. Sex differences in effects of predictable and unpredictable footshock on fentanyl self-administration in rats. Experimental and Clinical Psychopharmacology 1997, 5:99-106.
40. Kosten T.R., Kosten T.A., McDougle C.J., Hameedi F.A., McCance E.F., Rosen M.I., et al. Gender differences in response to intranasal cocaine administration to humans. Biological Psychiatry 1996, 39:147-148.
41. Kotlinska J.H., Gibula-Bruzda E., Pachuta A., Kunce D., Witkowska E., Chung N.N., et al. Influence of new deltorphin analogues on reinstatement of cocaine-induced conditioned place preference in rats. Behavioral Pharmacology 2010, 21:638-648.
42. Larson E.B., Roth M.E., Anker J.J., Carroll M.E. Effect of short- vs. long-term estrogen on reinstatement of cocaine-seeking behavior in female rats. Pharmacology Biochemistry and Behavior 2005, 82:98-108.
43. Ledoux V.A., Smejkalova T., May R.M., Cooke B.M., Woolley C.S. Estradiol facilitates the release of neuropeptide Y to suppress hippocampus-dependent seizures. Journal of Neuroscience 2009, 29:1457-1468.
44. Leranth C., Pickel V.M. Electron microscopic preembedding double-labeling methods. Neuroanatomical tract-tracing methods 2 1989, 129-172. Plenum Press, New York. 1 ed. L. Heimer, L. Zaborszky (Eds.).
45. Lujan R., Nusser Z., Roberts J.D., Shigemoto R., Somogyi P. Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendritic spines in the rat hippocampus. European Journal of Neuroscience 1996, 8:1488-1500.
46. Lynch W.J., Carroll M.E. Reinstatement of cocaine self-administration in rats: sex differences. Psychopharmacology 2000, 148:196-200.
47. Maccaferri G., McBain C.J. The hyperpolarization-activated current (Ih) and its contribution to pacemaker activity in rat CA1 hippocampal stratum oriens-alveus interneurones. Journal of Physiology 1996, 497(Pt 1):119-130.
48. Madamba S.G., Schweitzer P., Siggins G.R. Dynorphin selectively augments the M-current in hippocampal CA1 neurons by an opiate receptor mechanism. Journal of Neurophysiology 1999, 82:1768-1775.
49. Madison D.V., Nicoll R.A. Enkephalin hyperpolarizes interneurones in the rat hippocampus. Journal of Physiology 1988, 398:123-130.
50. Malenka R.C., Nicoll R.A. Long-term potentiation - A decade of progress?. Science 1999, 285:1870-1874.
51. Marcondes F.K., Bianchi F.J., Tanno A.P. Determination of the estrous cycle phases of rats: some helpful considerations. Brazilian Journal of Biology 2002, 62:609-614.
52. Marinelli P.W., Funk D., Harding S., Li Z., Juzytsch W., Le A.D. Roles of opioid receptor subtypes in mediating alcohol-seeking induced by discrete cues and context. European Journal of Neuroscience 2009, 30:671-678.
53. McEwen B.S. Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. Journal Of Applied Physiology 2001, 91:2785-2801.
54. McKay J.R., Rutherford M.J., Cacciola J.S., Kabasakalian-McKay R., Alterman A.I. Gender differences in the relapse experiences of cocaine patients. Journal of Nervous and Mental Disease 1996, 184:616-622.
55. Micevych P.E., Rissman E.F., Gustafsson J.A., Sinchak K. Estrogen receptor-alpha is required for estrogen-induced mu-opioid receptor internalization. Journal of Neuroscience Research 2003, 71:802-810.
56. Mills R.H., Sohn R.K., Micevych P.E. Estrogen-induced mu-opioid receptor internalization in the medial preoptic nucleus is mediated via neuropeptide Y-Y1 receptor activation in the arcuate nucleus of female rats. Journal of Neuroscience 2004, 24:947-955.
57. Milner T.A., McEwen B.S., Hayashi S., Li C.J., Reagan L.P., Alves S.E. Ultrastructural evidence that hippocampal alpha estrogen receptors are located at extranuclear sites. Journal of Comparative Neurology 2001, 429:355-371.
58. Milner T.A., Veznedaroglu E. Ultrastructural localization of neuropeptide Y-like immunoreactivity in the rat hippocampal formation. Hippocampus 1992, 2:107-125.
59. Moore S.D., Madamba S.G., Schweitzer P., Siggins G.R. Voltage-dependent effects of opioid peptides on hippocampal CA3 pyramidal neurons in vitro. Journal of Neuroscience 1994, 14:809-820.
60. Morgan M.M., Ashley M.D., Ingram S.L., Christie M.J. Behavioral consequences of delta-opioid receptor activation in the periaqueductal gray of morphine tolerant rats. Neural Plasticity 2009, 2009:516328.
61. Morinville A., Cahill C.M., Esdaile M.J., Aibak H., Collier B., Kieffer B.L., et al. Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. Journal of Neuroscience 2003, 23:4888-4898.
62. Moron J.A., Gullapalli S., Taylor C., Gupta A., Gomes I., Devi L.A. Modulation of opiate-related signaling molecules in morphine-dependent conditioned behavior: Conditioned place preference to morphine induces CREB phosphorylation. Neuropsychopharmacology 2010, 35:955-966.
63. Morris B.J., Johnston H.M. A role for hippocampal opioids in long-term functional plasticity. Trends in Neurosciences 1995, 18:350-355.
64. Nakamura N.H., Akama K.T., Yuen G.S., McEwen B.S. Thinking outside the pyramidal cell: Unexplored contributions of interneurons and neuropeptide Y to estrogen-induced synapse formation in the hippocampus. Review of Neuroscience 2007, 18:1-13.
65. Nakamura N.H., McEwen B.S. Changes in interneuronal phenotypes regulated by estradiol in the adult rat hippocampus: A potential role for neuropeptide Y. Neuroscience 2005, 136:357-369.
66. Nestler E.J. Neurobiology. Total recall-the memory of addiction. Science 2001, 292:2266-2267.
67. Nestler E.J. Common molecular and cellular substrates of addiction and memory. Neurobiology of Learning and Memory 2002, 78:637-647.
68. Neumaier J.F., Mailheau S., Chavkin C. Opioid receptor-mediated responses in the dentate gyrus and CA1 region of the rat hippocampus. Journal of Pharmacology and Experimental Therapeutics 1988, 244:564-570.
69. Persson A.I., Thorlin T., Eriksson P.S. Comparison of immunoblotted delta opioid receptor proteins expressed in the adult rat brain and their regulation by growth hormone. Neuroscience Research 2005, 52:1-9.
70. Persson P.A., Thorlin T., Ronnback L., Hansson E., Eriksson P.S. Differential expression of delta opioid receptors and mRNA in proliferating astrocytes during the cell cycle. Journal of Neuroscience Research 2000, 61:371-375.
71. Peters A., Palay S.L., Webster H.D. The fine structure of the nervous system 1991, Oxford University Press, New York.
72. Pierce J.P., Kurucz O.S., Milner T.A. Morphometry of a peptidergic transmitter system: dynorphin B-like immunoreactivity in the rat hippocampal mossy fiber pathway before and after seizures. Hippocampus 1999, 9:255-276.
73. Piguet P., North R.A. Opioid actions at mu and delta receptors in the rat dentate gyrus in vitro. Journal of Pharmacology and Experimental Therapeutics 1993, 266:1139-1149.
74. Pradhan A.A., Becker J.A., Scherrer G., Tryoen-Toth P., Filliol D., Matifas A., et al. In vivo delta opioid receptor internalization controls behavioral effects of agonists. PLoS One 2009, 4:e5425.
75. Pu L., Bao G.B., Xu N.J., Ma L., Pei G. Hippocampal long-term potentiation is reduced by chronic opiate treatment and can be restored by re-exposure to opiates. Journal of Neuroscience 2002, 22:1914-1921.
76. Rall W. Distinguishing theoretical synaptic potentials computed for different soma-dendritic distributions of synaptic input. Journal of Neurophysiology 1967, 30:1138-1168.
77. Robbins S.J., Ehrman R.N., Childress A.R., O'Brien C.P. Comparing levels of cocaine cue reactivity in male and female outpatients. Drug And Alcohol Dependence. 1999, 53:223-230.
78. Robbins T.W., Everitt B.J. Drug addiction: Bad habits add up. Nature 1999, 398:567-570.
79. Roman E., Ploj K., Gustafsson L., Meyerson B.J., Nylander I. Variations in opioid peptide levels during the estrous cycle in Sprague-Dawley rats. Neuropeptides 2006, 40:195-206.
80. Rubin A., Stout R.L., Longabaugh R. Gender differences in relapse situations. Addiction 1996, 91(Suppl.):S111-S120.
81. Saland L.C., Hastings C.M., Abeyta A., Chavez J.B. Chronic ethanol modulates delta and mu-opioid receptor expression in rat CNS: Immunohistochemical analysis with quantitiative confocal microscopy. Neuroscience Letters 2005, 381:163-168.
82. Scherrer G., Tryoen-Toth P., Filliol D., Matifas A., Laustriat D., Cao Y.Q., et al. Knockin mice expressing fluorescent delta-opioid receptors uncover G protein-coupled receptor dynamics in vivo. Proceedings of The National Academy of Sciences of the United States of America 2006, 103:9691-9696.
83. Shippenberg T.S., Chefer V.I., Thompson A.C. Delta-opioid receptor antagonists prevent sensitization to the conditioned rewarding effects of morphine. Biological Psychiatry 2009, 65:169-174.
84. Sik A., Penttonen M., Ylinen A., Buzsaki G. Hippocampal CA1 interneurons: An in vivo intracellular labeling study. Journal of Neuroscience 1995, 15:6651-6665.
85. Sinchak K., Micevych P.E. Progesterone blockade of estrogen activation of mu-opioid receptors regulates reproductive behavior. Journal of Neuroscience 2001, 21:5723-5729.
86. Stumm R.K., Zhou C., Schulz S., Hollt V. Neuronal types expressing mu- and delta-opioid receptor mRNA in the rat hippocampal formation. Journal of Comparative Neurology 2004, 469:107-118.
87. Svoboda K.R., Adams C.E., Lupica C.R. Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons. Journal of Neuroscience 1999, 19:85-95.
88. Svoboda K.R., Lupica C.R. Opioid inhibition of hippocampal interneurons via modulation of potassium and hyperpolarization-activated cation (Ih) currents. Journal of Neuroscience 1998, 18:7084-7098.
89. Swanson L.W. Brain maps: Structure of the rat brain 2000, Academic Press, San Diego, CA. 2nd ed.
90. Tanapat P., Hastings N.B., Gould E. Ovarian steroids influence cell proliferation in the dentate gyrus of the adult female rat in a dose- and time-dependent manner. Journal of Comparative Neurology 2005, 481:252-265.
91. Torres-Reveron A., Khalid S., Williams T.J., Waters E.M., Drake C.T., McEwen B.S., et al. Ovarian steroids modulate leu-enkephalin levels and target leu-enkephalinergic profiles in the female hippocampal mossy fiber pathway. Brain Research 2008, 1232:70-84.
92. Torres-Reveron A., Khalid S., Williams T.J., Waters E.M., Jacome L., Luine V.N., et al. Hippocampal dynorphin immunoreactivity increases in response to gonadal steroids and is positioned for direct modulation by ovarian steroid receptors. Neuroscience 2009, 159:204-216.
93. Torres-Reveron A., Williams T.J., Chapleau J.D., Waters E.M., McEwen B.S., Drake C.T., et al. Ovarian steroids alter mu opioid receptor trafficking in hippocampal parvalbumin GABAergic interneurons. Experimental Neurology 2009, 219:319-327.
94. Towart L.A., Alves S.E., Znamensky V., Hayashi S., McEwen B.S., Milner T.A. Subcellular relationships between cholinergic terminals and estrogen receptor-alpha in the dorsal hippocampus. Journal of Comparative Neurology 2003, 463:390-401.
95. Tsao P.I., von Zastrow M. Type-specific sorting of G protein-coupled receptors after endocytosis. Journal of Biological Chemistry 2000, 275:11130-11140.
96. Turner C.D., Bagnara J.T. General endocrinology 1971, W.B. Saunders, Philadelphia.
97. Vathy I., Rimanoczy A., Slamberova R. Prenatal exposure to morphine differentially alters gonadal hormone regulation of delta-opioid receptor binding in male and female rats. Brain Research Bulletin 2000, 53:793-800.
98. Vetter P., Roth A., Hausser M. Propagation of action potentials in dendrites depends on dendritic morphology. Journal of Neurophysiology 2001, 85:926-937.
99. White N.M. Addictive drugs as reinforcers: Multiple partial actions on memory systems. Addiction 1996, 91:921-949.
100. Williams T.J., Mitterling K.L., Thompson L.I., Torres-Reveron A., Waters E.M., McEwen B.S., et al. Age- and hormone-regulation of opioid peptides and synaptic proteins in the rat dorsal hippocampal formation. Brain Research 2010.
101. Wilson M.A., Mascagni F., McDonald A.J. Sex differences in delta opioid receptor immunoreactivity in rat medial amygdala. Neuroscience Letters 2002, 328:160-164.
102. Woolley C.S., McEwen B.S. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. Journal of Neuroscience 1992, 12:2549-2554.
103. Xie C.W., Lewis D.V. Depression of LTP in rat dentate gyrus by naloxone is reversed by GABAA blockade. Brain Research 1995, 688:56-60.
104. Xie C.W., Lewis D.V. Endogenous opioids regulate long-term potentiation of synaptic inhibition in the dentate gyrus of rat hippocampus. Journal of Neuroscience 1995, 15:3788-3795.
105. Yanovsky Y., Sergeeva O.A., Freund T.F., Haas H.L. Activation of interneurons at the stratum oriens/alveus border suppresses excitatory transmission to apical dendrites in the CA1 area of the mouse hippocampus. Neuroscience 1997, 77:87-96.